The market value of Kymera Therapeutics Inc (KYMR) Stock is expected to soar in the coming months
Oppenheimer raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “an Outperform”. The rating was released on April 22, 2024, according to finviz. The stock was downgraded by BofA Securities, who disclosed in a research note on January 03, 2024, from Buy to Neutral and set the price objective to $30. In […]
A positive surprise is on the way: Kymera Therapeutics Inc (KYMR) Stock
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
Kymera Therapeutics Inc (KYMR) Stock offers help to cash-strapped investors
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
Is Kymera Therapeutics Inc (KYMR) Stock a good value investment?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
What does Kymera Therapeutics Inc (KYMR) Stock have to offer?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
Would Kymera Therapeutics Inc (KYMR) Stock like to attract the attention of traders?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
What is happening with Kymera Therapeutics Inc (KYMR) Stock?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]